
Scripts Rx Direct Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: compounded peptides priced up front, including KPV, MOTS-c, epitalon and semax nasal spray
Scripts Rx Direct scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Scripts Rx Direct is a telehealth platform selling compounded GLP-1s and peptides, including five of the six peptides on the October 2026 HHS 503A list. A one-month supply of compounded semaglutide is listed at $200 and tirzepatide at $247, and every catalog price is shown before checkout. Its terms and privacy pages are unfinished templates that name no company, address or pharmacy.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Scripts Rx Direct
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
ShedRx
Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
Editorial score · methodology
bmiMD
Best for: one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan
Editorial score · methodology
Scripts Rx Direct at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $200/mo
- FDA status
- No FDA warning letter on record
How we scored Scripts Rx Direct
Each dimension is scored algorithmically from Scripts Rx Direct’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.4/10At $200/mo, Scripts Rx Direct runs about 12% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.9/10Scripts Rx Direct offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience; 6 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
5.9/10Scripts Rx Direct's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.7/10Scripts Rx Direct provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Scripts Rx Direct review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $200–$247/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Scripts Rx Direct
We walked Scripts Rx Direct’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the public treatment catalog, where each listing shows its price and supply before any account
- 2Open a product page, which repeats the price and lists what is included
- 3Answer three preliminary questions, starting with 'Are you 18 or older?', before checkout opens
- 4Checkout and the medical intake run on GEN Health's platform (app.genhealthehr.com); stopped at the first preliminary question
- Prices are public for every listed treatment, but the FAQ says checkout adds shipping and any assessment fees, so the catalog figure may not be the final total.
- The peptide pages say provider review and shipping are included; the GLP-1 pages list provider review but do not say the medication or shipping is included.
- The legal pages are unfinished templates: no effective date, company name, address or payment processor is filled in.
- We did not create an account, enter health information or reach payment.
Scripts Rx Direct customer support
GLP-1 medications Scripts Rx Direct offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Scripts Rx Direct offers
Beyond GLP-1s, Scripts Rx Direct also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Catalog price $200 for 'Semaglutide, 1 month'; a 3-month offer is listed at $400. The site says checkout shows the final total, shipping and any assessment fees.
Catalog price $247 for 'Tirzepatide, 1 month'; a 3-month offer is listed at $549. Final total, shipping and any assessment fees appear at checkout.
Ready to get started?
Plans and promotions change often, so check Scripts Rx Direct's current pricing and active discounts before you decide.
What we like
- Every treatment shows its price before checkout, from $129 for oral BPC-157 to $247 for a month of tirzepatide.
- Sells KPV, MOTS-c, epitalon and semax as single-ingredient products, each with a 1-month or 3-month supply.
- Semax is sold as a nasal spray, the only form the HHS policy covers for it.
- A 3-month supply lowers the monthly cost on peptides, for example semax drops from $149 to about $133 a month.
- States plainly that compounded drugs are not FDA-approved and that checkout does not guarantee a prescription.
Watch-outs
- Its terms, privacy and consent pages are unfinished templates, with placeholders such as 'CONTACT EMAIL' and 'MAILING ADDRESS'.
- No legal entity, business address or compounding pharmacy is named anywhere on the site.
- No LegitScript certification: the LegitScript lookup for the domain returns only its generic search form.
- KPV is sold only as an injection, a form the HHS policy does not cover (it covers topical and oral KPV).
- TB-500 is sold only mixed with BPC-157 in one vial, while the HHS policy covers single-ingredient products only.
- The site does not list which states it serves.
- Support is email only, and the address uses a different domain (scriptsrx.com).
Is Scripts Rx Direct worth it?
Scripts Rx Direct built its program around one core idea: compounded peptides priced up front, including KPV, MOTS-c, epitalon and semax nasal spray. It runs $200/month, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. It's a fairly plain, no-frills entry in the GLP-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
How much Scripts Rx Direct costs
Compounded semaglutide runs $200/month and compounded tirzepatide runs $247/month.
That's roughly in line with the ~$179/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, Belle Health runs semaglutide and tirzepatide from $199/month, so compare it with Scripts Rx Direct before you commit.
Medications: what Scripts Rx Direct prescribes
Scripts Rx Direct prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Scripts Rx Direct is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program without a lot of extra features to evaluate.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Scripts Rx Direct dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Scripts Rx Direct is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Scripts Rx Direct scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Scripts Rx Direct?
From $200/mo. See current pricing and start your free consultation.
Scripts Rx Direct might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Scripts Rx Direct vs…
Scripts Rx Direct scores6.9/10
Side-by-side pricing, medications and scores. Pick a matchup.
Scripts Rx Direct vs Amazon One Medical
Amazon One Medical scores 8.5/10

Scripts Rx Direct vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Scripts Rx Direct review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Scripts Rx Direct's current pricing
Plans from $200/mo. Start your free consultation to check eligibility and today's price.